Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-04

Clinical Trial Update: Single Dose Azithromycin to Prevent Cholera in Children [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating whether a single dose of azithromycin can prevent cholera in children. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cholera | Phase 2 | Status: ACTIVE_NOT_RECRUITING